ID   PDPN_RAT                Reviewed;         166 AA.
AC   Q64294; O08731; O55210;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 132.
DE   RecName: Full=Podoplanin {ECO:0000303|PubMed:9327748};
DE   AltName: Full=E11 antigen epitope {ECO:0000303|PubMed:8833206};
DE   AltName: Full=RTI140 {ECO:0000303|PubMed:9761764, ECO:0000303|PubMed:9920397};
DE   AltName: Full=T1-alpha {ECO:0000303|PubMed:7851650};
DE            Short=T1A {ECO:0000303|PubMed:7851650};
DE   AltName: Full=Type I cell 40 kDa protein;
DE   Flags: Precursor;
GN   Name=Pdpn {ECO:0000312|RGD:61819};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Lung;
RX   PubMed=7851650; DOI=10.1006/dbio.1995.1024;
RA   Rishi A.K., Joyce-Brady M., Fisher J., Dobbs L.G., Floros J.,
RA   Vanderspek J., Brody J.S., Williams M.C.;
RT   "Cloning, characterization, and development expression of a rat lung
RT   alveolar type I cell gene in embryonic endodermal and neural derivatives.";
RL   Dev. Biol. 167:294-306(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Osteosarcoma;
RX   PubMed=8833206; DOI=10.1016/8756-3282(95)00457-2;
RA   Wetterwald A., Hoffstetter W., Cecchini M.G., Lanske B., Wagner C.,
RA   Fleisch H., Atkinson M.;
RT   "Characterization and cloning of the E11 antigen, a marker expressed by rat
RT   osteoblasts and osteocytes.";
RL   Bone 18:125-132(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   DEVELOPMENTAL STAGE, AND DOWN-REGULATION IN PAN.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=9327748;
RA   Breiteneder-Geleff S., Matsui K., Soleiman A., Meraner P., Poczewski H.,
RA   Kalt R., Schaffner G., Kerjaschki D.;
RT   "Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells,
RT   is down-regulated in puromycin nephrosis.";
RL   Am. J. Pathol. 151:1141-1152(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=9761764; DOI=10.1165/ajrcmb.19.4.3121;
RA   Vanderbilt J.N., Dobbs L.G.;
RT   "Characterization of the gene and promoter for RTI40, a differentiation
RT   marker of type I alveolar epithelial cells.";
RL   Am. J. Respir. Cell Mol. Biol. 19:662-671(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 41-55, GLYCOSYLATION, AND BLOCKAGE OF N-TERMINUS.
RX   PubMed=9920397; DOI=10.1016/s0167-4838(98)00231-3;
RA   Gonzalez R.F., Dobbs L.G.;
RT   "Purification and analysis of RTI40, a type I alveolar epithelial cell
RT   apical membrane protein.";
RL   Biochim. Biophys. Acta 1429:208-216(1998).
CC   -!- FUNCTION: Mediates effects on cell migration and adhesion through its
CC       different partners. During development plays a role in blood and
CC       lymphatic vessels separation by binding CLEC1B, triggering CLEC1B
CC       activation in platelets and leading to platelet activation and/or
CC       aggregation. Interaction with CD9, on the contrary, attenuates platelet
CC       aggregation and pulmonary metastasis induced by PDPN. Mediates effects
CC       on cell migration and adhesion through its different partners. Through
CC       MSN or EZR interaction promotes epithelial-mesenchymal transition (EMT)
CC       leading to ERZ phosphorylation and triggering RHOA activation leading
CC       to cell migration increase and invasiveness. Interaction with CD44
CC       promotes directional cell migration in epithelial and tumor cells (By
CC       similarity). In lymph nodes (LNs), controls fibroblastic reticular
CC       cells (FRCs) adhesion to the extracellular matrix (ECM) and contraction
CC       of the actomyosin by maintaining ERM proteins (EZR; MSN and RDX) and
CC       MYL9 activation through association with unknown transmembrane
CC       proteins. Engagement of CLEC1B by PDPN promotes FRCs relaxation by
CC       blocking lateral membrane interactions leading to reduction of ERM
CC       proteins (EZR; MSN and RDX) and MYL9 activation (By similarity).
CC       Through binding with LGALS8 may participate in connection of the
CC       lymphatic endothelium to the surrounding extracellular matrix. In
CC       keratinocytes, induces changes in cell morphology showing an elongated
CC       shape, numerous membrane protrusions, major reorganization of the actin
CC       cytoskeleton, increased motility and decreased cell adhesion. Controls
CC       invadopodia stability and maturation leading to efficient degradation
CC       of the extracellular matrix (ECM) in tumor cells through modulation of
CC       RHOC activity in order to activate ROCK1/ROCK2 and LIMK1/LIMK2 and
CC       inactivation of CFL1 (By similarity). Required for normal lung cell
CC       proliferation and alveolus formation at birth (By similarity). Does not
CC       function as a water channel or as a regulator of aquaporin-type water
CC       channels (By similarity). Does not have any effect on folic acid or
CC       amino acid transport (By similarity). {ECO:0000250|UniProtKB:Q62011,
CC       ECO:0000250|UniProtKB:Q86YL7}.
CC   -!- SUBUNIT: Homodimer. Interacts with CLEC1B; the interaction is
CC       independent of CLEC1B glycosylation and activates CLEC1B; the
CC       interaction is dependent of sialic acid on O-glycans. Interacts with
CC       CD9; this interaction is homophilic and attenuates platelet aggregation
CC       and pulmonary metastasis induced by PDPN. Interacts with LGALS8; the
CC       interaction is glycosylation-dependent; may participate in connection
CC       of the lymphatic endothelium to the surrounding extracellular matrix.
CC       Interacts with HSPA9. Interacts (via extracellular domain) with CD44;
CC       this interaction is required for PDPN-mediated directional migration
CC       and regulation of lamellipodia extension/stabilization during cell
CC       spreading and migration. Interacts (via cytoplasmic domain) with MSN
CC       and EZR; activates RHOA and promotes epithelial-mesenchymal transition.
CC       Interacts with CCL21; relocalized PDPN to the basolateral membrane.
CC       {ECO:0000250|UniProtKB:Q86YL7}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:9327748}; Single-
CC       pass type I membrane protein {ECO:0000255}. Cell projection,
CC       lamellipodium membrane {ECO:0000269|PubMed:9327748}; Single-pass type I
CC       membrane protein {ECO:0000255}. Cell projection, filopodium membrane
CC       {ECO:0000269|PubMed:9327748}; Single-pass type I membrane protein
CC       {ECO:0000255}. Cell projection, microvillus membrane
CC       {ECO:0000269|PubMed:9327748}; Single-pass type I membrane protein
CC       {ECO:0000255}. Cell projection, ruffle membrane
CC       {ECO:0000269|PubMed:9327748}; Single-pass type I membrane protein
CC       {ECO:0000255}. Membrane raft {ECO:0000250|UniProtKB:Q86YL7}. Apical
CC       cell membrane {ECO:0000250|UniProtKB:Q86YL7}. Basolateral cell membrane
CC       {ECO:0000250|UniProtKB:Q86YL7}. Cell projection, invadopodium
CC       {ECO:0000250|UniProtKB:Q86YL7}. Note=Localized to actin-rich microvilli
CC       and plasma membrane projections such as filopodia, lamellipodia and
CC       ruffles (PubMed:9327748). Association to the lipid rafts is required
CC       for PDPN-induced epithelial to mesenchymal transition (EMT).
CC       Colocalizes with CD9 in tetraspanin microdomains. Localized at
CC       invadopodium adhesion rings in tumor cell. Association to the lipid
CC       rafts is essential for PDPN recruitment to invadopodia and ECM
CC       degradation (By similarity). {ECO:0000250|UniProtKB:Q86YL7,
CC       ECO:0000269|PubMed:9327748}.
CC   -!- TISSUE SPECIFICITY: In adult kidney, expressed on the urinary surface
CC       and foot processes of podocytes and in parietal epithelial cells of
CC       Bowman's capsule where it is localized to luminal surfaces. In lung,
CC       expressed exclusively on luminal surfaces of type I alveolar epithelial
CC       cells and pleural mesothelial cells. Not expressed in type II alveolar
CC       cells. In bone, expressed in osteocytes and osteoblasts. In spleen,
CC       liver, stomach and intestine, expressed in mesoepithelium. Also
CC       expressed in thymic epithelial cells, choroid plexus and leptomeninges.
CC       {ECO:0000269|PubMed:9327748, ECO:0000269|PubMed:9761764}.
CC   -!- DEVELOPMENTAL STAGE: In newborn kidney, not detected at the vesicle
CC       stage. First detected in S-shaped bodies. {ECO:0000269|PubMed:9327748}.
CC   -!- DOMAIN: The cytoplasmic domain controls FRC elongation but is
CC       dispensable for contraction (By similarity). The cytoplasmic domain is
CC       essential for recruitment to invadopodia and ECM degradation (By
CC       similarity). {ECO:0000250|UniProtKB:Q62011,
CC       ECO:0000250|UniProtKB:Q86YL7}.
CC   -!- PTM: Extensively O-glycosylated. Contains sialic acid residues. O-
CC       glycosylation is necessary for platelet aggregation activity.
CC       Disialylated at Thr-52; sialic acid is critical for platelet-
CC       aggregating activity and for CLEC1B interaction (By similarity).
CC       {ECO:0000250|UniProtKB:Q86YL7, ECO:0000269|PubMed:9920397}.
CC   -!- PTM: The N-terminus is blocked. {ECO:0000269|PubMed:9920397}.
CC   -!- MISCELLANEOUS: Down-regulated in puromycin aminonucleoside nephrosis
CC       (PAN).
CC   -!- SIMILARITY: Belongs to the podoplanin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U07797; AAA92789.1; -; mRNA.
DR   EMBL; U32115; AAA74431.1; -; mRNA.
DR   EMBL; U96449; AAB86438.1; -; mRNA.
DR   EMBL; U92440; AAB93880.1; -; Genomic_DNA.
DR   EMBL; U92081; AAB93880.1; JOINED; Genomic_DNA.
DR   EMBL; BC072492; AAH72492.1; -; mRNA.
DR   RefSeq; NP_062231.1; NM_019358.1.
DR   AlphaFoldDB; Q64294; -.
DR   SMR; Q64294; -.
DR   CORUM; Q64294; -.
DR   STRING; 10116.ENSRNOP00000020316; -.
DR   GlyCosmos; Q64294; 18 sites, No reported glycans.
DR   GlyGen; Q64294; 18 sites.
DR   PhosphoSitePlus; Q64294; -.
DR   PaxDb; 10116-ENSRNOP00000020316; -.
DR   Ensembl; ENSRNOT00065046427; ENSRNOP00065038067; ENSRNOG00065026882.
DR   GeneID; 54320; -.
DR   KEGG; rno:54320; -.
DR   UCSC; RGD:61819; rat.
DR   AGR; RGD:61819; -.
DR   CTD; 10630; -.
DR   RGD; 61819; Pdpn.
DR   eggNOG; ENOG502QRWU; Eukaryota.
DR   InParanoid; Q64294; -.
DR   OrthoDB; 5229785at2759; -.
DR   PhylomeDB; Q64294; -.
DR   TreeFam; TF337068; -.
DR   Reactome; R-RNO-114604; GPVI-mediated activation cascade.
DR   PRO; PR:Q64294; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0042995; C:cell projection; ISS:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0030175; C:filopodium; ISS:UniProtKB.
DR   GO; GO:0031527; C:filopodium membrane; ISS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0031258; C:lamellipodium membrane; ISS:UniProtKB.
DR   GO; GO:0061851; C:leading edge of lamellipodium; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0031528; C:microvillus membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0001726; C:ruffle; ISS:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; ISS:UniProtKB.
DR   GO; GO:0097197; C:tetraspanin-enriched microdomain; ISS:UniProtKB.
DR   GO; GO:0019956; F:chemokine binding; ISO:RGD.
DR   GO; GO:0051087; F:protein-folding chaperone binding; ISO:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISS:UniProtKB.
DR   GO; GO:0070252; P:actin-mediated cell contraction; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IDA:MGI.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; ISO:RGD.
DR   GO; GO:0048286; P:lung alveolus development; ISO:RGD.
DR   GO; GO:0030324; P:lung development; IEP:RGD.
DR   GO; GO:0048535; P:lymph node development; ISS:UniProtKB.
DR   GO; GO:0001946; P:lymphangiogenesis; ISS:UniProtKB.
DR   GO; GO:0060838; P:lymphatic endothelial cell fate commitment; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; IEP:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IDA:MGI.
DR   GO; GO:2000147; P:positive regulation of cell motility; ISO:RGD.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISS:UniProtKB.
DR   GO; GO:0090091; P:positive regulation of extracellular matrix disassembly; ISS:UniProtKB.
DR   GO; GO:0010572; P:positive regulation of platelet activation; IMP:RGD.
DR   GO; GO:1901731; P:positive regulation of platelet aggregation; ISS:UniProtKB.
DR   GO; GO:0006693; P:prostaglandin metabolic process; ISO:RGD.
DR   GO; GO:0030155; P:regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   GO; GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:2000392; P:regulation of lamellipodium morphogenesis; ISS:UniProtKB.
DR   GO; GO:1904328; P:regulation of myofibroblast contraction; ISS:UniProtKB.
DR   GO; GO:1900024; P:regulation of substrate adhesion-dependent cell spreading; ISS:UniProtKB.
DR   GO; GO:0055093; P:response to hyperoxia; IEP:RGD.
DR   GO; GO:0007266; P:Rho protein signal transduction; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0035239; P:tube morphogenesis; IDA:MGI.
DR   GO; GO:0044319; P:wound healing, spreading of cells; ISS:UniProtKB.
DR   InterPro; IPR052684; Podoplanin_domain.
DR   PANTHER; PTHR47390; PODOPLANIN; 1.
DR   PANTHER; PTHR47390:SF1; PODOPLANIN; 1.
DR   Pfam; PF05808; Podoplanin; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Cell shape;
KW   Developmental protein; Direct protein sequencing; Glycoprotein; Membrane;
KW   Reference proteome; Sialic acid; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000250|UniProtKB:Q86YL7"
FT   CHAIN           23..166
FT                   /note="Podoplanin"
FT                   /id="PRO_0000021353"
FT   TOPO_DOM        23..135
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        136..156
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        157..166
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          54..124
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          137..141
FT                   /note="Requires for dimerization and lipid rafts
FT                   association"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YL7"
FT   REGION          158..159
FT                   /note="Requires for interaction with MSN and EZR"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YL7"
FT   COMPBIAS        81..96
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        34
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        52
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86YL7"
FT   CARBOHYD        55
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        56
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        62
FT                   /note="O-linked (GalNAc...) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        63
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        71
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        80
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        81
FT                   /note="O-linked (GalNAc...) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        83
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        84
FT                   /note="O-linked (GalNAc...) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        94
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        95
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        96
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        101
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        105
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        109
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        110
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        112
FT                   /note="P -> S (in Ref. 3; AAB86438 and 5; AAH72492)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        135..137
FT                   /note="LVG -> WSA (in Ref. 4; AAB93880)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   166 AA;  17579 MW;  B97C58292B664468 CRC64;
     MWTAPVLLWV LGSVWFWDSA QGGAIGALED DLVTPGPGDD MVNPGLEDRI ETTDTTGELD
     KSTAKAPLVP TQPPIEELPT SGTSDHDHKE HESTTTVKAV TSHSTDKKTT HPNRDNAGGE
     TQTTDKKDGL AVVTLVGIII GVLLAIGFIG GIIIVVMRKI SGRFSP
//
